Laboratory of Food and Regulation Biology Department of Bioscience, School of Agriculture, Tokai University, Kawayou Minamiaso Aso-gun, Kumamoto, 869-1404, Japan,
Amino Acids. 2014 Feb;46(2):261-6. doi: 10.1007/s00726-013-1487-z. Epub 2013 Mar 17.
Since advanced glycation end-products (AGEs) inhibitors such as benfotiamine, pyridoxamine and aminoguanidine significantly inhibit the development of retinopathy and neuropathy in streptozotocin-induced diabetic rats, treatment with AGEs inhibitors is believed to be a potential strategy for preventing lifestyle-related diseases such as diabetic complications and atherosclerosis. Furthermore, preventive medicine is the most important approach to preventing lifestyle-related diseases, and improving daily nutritional intake is thought to prevent the pathogenesis of such diseases. Therefore, AGEs inhibitors that can be obtained from daily meals are preferred to prescribed drugs. In this article, we describe a strategy for developing new AGEs inhibitors from natural products.
由于苯磷汀、吡哆胺和氨基胍等晚期糖基化终产物(AGEs)抑制剂可显著抑制链脲佐菌素诱导的糖尿病大鼠视网膜病变和神经病变的发展,因此,使用 AGEs 抑制剂被认为是预防糖尿病并发症和动脉粥样硬化等生活方式相关疾病的一种潜在策略。此外,预防医学是预防生活方式相关疾病最重要的方法,改善日常营养摄入被认为可以预防这些疾病的发病机制。因此,从日常饮食中获得的 AGEs 抑制剂优于处方药物。本文介绍了一种从天然产物中开发新型 AGEs 抑制剂的策略。